Trials / Recruiting
RecruitingNCT05626491
Electrical Stimulation for the Treatment of Glaucoma
Evaluate the Safety and Efficacy of Repetitive, Transorbital Alternating Current Stimulation (rtACS) for the Treatment of Glaucoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Repetitive, Transorbital Alternating Current Stimulation (rtACS) | Patients receive treatment every other day via a headband that delivers electrical stimulation to the retina |
| DEVICE | Sham Repetitive, Transorbital Alternating Current Stimulation (rtACS) | Patients receive sham treatment (no active stimulation) every other day via a headband. |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2022-11-23
- Last updated
- 2024-12-04
Locations
4 sites across 2 countries: United States, Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05626491. Inclusion in this directory is not an endorsement.